Iranians Face Anxious Wait Amid Attack Threat
Iranians face growing anxiety as reports describe a possible attack, but available sources do not confirm its timing, location, targets, or civilian impact.
400,000 Reportedly Protest Across France as Paris Clashes Erupt
More than 400,000 people reportedly protested across France, while clashes in Paris intensified pressure on President Emmanuel Macron. Key details remain unverified.
California Dispute Over Alleged Noncitizen Voting
California officials criticized a reported Justice Department request to identify suspected noncitizen voters, raising questions about evidence, federal authority, and due process.
TPD: 11 Shot Near FAMU, Six of Them Juveniles
Tallahassee Police report 11 people shot near Florida A&M University, six of them juveniles. Location, injuries, suspect and motive remain unconfirmed.
Democrats Seek Dismissal of Alaska Senate Challenge
Democrats and voting-rights groups oppose the Trump administration’s challenge to Alaska’s Senate election, warning it could delay certification.
Oregon Man Regrets Children He Could Not Save
An Oregon man who reportedly killed a school shooter says he still regrets being unable to save children who died during the attack.
Six Flags to Add Seatbelts After Goliath Death
Six Flags plans to add seatbelts to selected roller coasters, including Goliath in Georgia, after a rider died following a fall. The cause remains under investigation.
Ondrej Suri and the Hidden Work Keeping PHP Secure
Ondrej Suri’s reported PHP maintenance work highlights the overlooked specialists, automation, and open-source communities that keep the web reliable.
Amgen Reports 58% Lower Death Risk in Lung Cancer Trial
Amgen reported that IMDELLTRA plus IMFINZI reduced the risk of death by 58% in first-line extensive-stage small cell lung cancer, but full trial data remain needed.
Merck Executive Unruffled by Cancer Vaccine Data Leak
A Merck executive reportedly called an early leak of ESMO cancer vaccine data “unfortunate,” but the disclosure does not establish the vaccine’s efficacy, safety, or regulatory prospects.